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The impact of waist circumference on function
and physical activity in older adults: longitudinal
observational data from the osteoarthritis
initiative
John A Batsis1,2,3*, Alicia J Zbehlik2,3,4,5, Laura K Barre3,5,6, Todd A Mackenzie2,3,5 and Stephen J Bartels2,3,5

Abstract
Background: We previously demonstrated that BMI is associated with functional decline and reduced quality of
life. While BMI in older adults is fraught with challenges, waist circumference (WC) is a marker of visceral adiposity
that can also predict mortality. However, its association with function and quality of life in older adults is not well
understood and hence we sought to examine the impact of WC on six-year outcomes.
Methods: We identified adults aged ≥60 years from the longitudinal Osteoarthritis Initiative and stratified the
cohort into quartiles based on WC. Our primary outcome measures of function at six year follow-up included:
self-reported quality of life [Short Form-12 (SF-12)], physical function [Physical Activity Scale for the Elderly (PASE)]
and disability [Late-life Disability Index (LLDI)]. Linear regression analyses predicted 6-year outcomes based on WC
quartile category (lowest = referent), adjusted for age, sex, race, education, knee pain, smoking status, a modified
Charlson co-morbidity index and baseline scores, where available.
Results: We identified 2,182 subjects meeting our inclusion criteria and stratified the study cohort by quartiles of
WC. Mean age ranged from 67.5-68.7 years, 60-71% were female and 80-86% were white. The highest WC quartile
compared to 50-75th, 25-50th or lowest quartile, was associated with a greater number of medications (4.3, 4.0, 3.6
and 3.4 [p < 0.001]), lower gait speeds (1.23, 1.27, 1.32, and 1.34 m/s[p < 0.001]), higher rates of knee osteoarthritis
(70.2, 62.2, 60.2, 48.6;p < 0.001), higher Charlson co-morbidity scores and greater knee pain (WOMAC scores) (all
p < 0.001). At follow-up, adjusted SF-12 physical function subscale and PASE scores, were lowest in the highest WC
quartile as compared to the 50-75%, 25-50%, and lowest quartiles [(SF-12 scores: 45.5, 46.7, 47.6, and 47.9), and
(PASE scores: 109.6, 128.7, 126.6, and 131.0). The LLDI limitation subscale for disability demonstrated lower scores in
the high WC quartile as opposed to the referent group.
Conclusions: Elevated WC is associated with lower quality of life, a decline in physical function, and a slightly
higher risk of disability over time. Intervention studies are needed to prevent functional decline in this high-risk
population.
Keywords: Obesity, Waist circumference, Osteoarthritis, Disability, Physical activity, Quality of life
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Background
A number of physiological alterations occur during the
aging process leading to impairments in activities of
daily living that can lead to disability, institutionalization
and death [1]. Osteoarthritis (OA) is an increasingly
prevalent cause of functional decline and can augment the
changes in body composition that occur with aging [2,3].
The observed decline in mobility subsequently places
older adults at increased risk of falls and dependency.
Along with the rising number of older adults, the
prevalence of obesity measured by body mass index continues to rise. A recent population-based survey in the
United States found that 35% of older adults are obese
[4], paralleling the prevalence observed in the general
population. Adiposity is associated with increased cardiometabolic risk [5], and in older adults can lead to diminished quality of life and disability [6,7]. Yet, BMI-defined
obesity has poor sensitivity and specificity in identifying
adiposity [8], and cannot distinguish between subcutaneous and visceral adiposity.
Waist circumference (WC) has been proposed as a
relatively inexpensive measure of visceral adiposity. An
elevated WC is one of five criteria that define the metabolic syndrome [9], which itself has been associated with
functional decline, frailty and disability [10]. Crosssectional and longitudinal studies suggest an association
of increased BMI with mobility impairments [11]. However, to our knowledge, there have been few longitudinal
studies of older adults examining whether WC as a surrogate marker for visceral adiposity is associated with distal
geriatric outcomes, including falls, functional decline and
quality of life [11,12].
Obesity is a major risk factor for increasing severity of
early degenerative changes and cartilaginous lesion progression of knee OA [13], placing older patients at risk
for worsened musculoskeletal disorders and functional
decline [14,15]. We previously demonstrated in this cohort that obesity, measured using a body mass index
(BMI) ≥30 kg/m2, is associated with reduced quality of
life, reduced physical activity and increased risk of disability [Batsis Submitted Public Health Nutrition] Examining
the impact of central adiposity in this high-risk population
allows clinicians not only to determine whether WC is a
harbinger of disability but also whether it can be used as
an alternative anthropometric measure. We hypothesize
that in a cohort of older adults at risk for OA, that longterm quality of life, physical activity and activities of daily
living are compromised in older adults with elevated WC.
Methods
The Osteoarthritis Initiative (OAI) is a multi-center,
longitudinal, prospective observational study of osteoarthritis in adults. Data collection began in 2004 and is
gathered at four clinical sites: Baltimore, MD, Pawtuckett,
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RI, Pittsburgh, PA, and Columbus, OH. The study is
funded by the National Institute of Arthritis, Musculoskeletal and Skin Diseases.
Subjects were recruited through mailings, advertisements, and community meetings. To ascertain subject
eligibility, a telephone interview was conducted, and if
eligible, subjects attended a screening clinic visit where
additional assessments were performed. Baseline data including questionnaires, interviews, and physical assessments were collected at an enrollment clinic visit. All
such visits occurred within a six-week period. Inclusion
criteria included recruiting equal numbers of males and
females, aged 45–79 years, and all ethnic groups were
eligible for the study. Patients were excluded if they had
rheumatoid arthritis, severe joint space narrowing; bilateral total knee replacements; inability to undergo an MRI;
unable to provide blood samples; comorbidity preventing
study participation; unlikely to be resident in the area for
at least 3 years; other research participation; and unwillingness to sign an informed consent. Protocols are available online for full review. All data is freely available for
download at http://www.oai.ucsf.edu/. Participants completed follow up assessments at yearly intervals and most
recent study follow-up consists of six year data. For this
study, baseline and six-year outcome data was used. Our
local institutional review board, the Committee for the
Protection of Human Subjects (CPHS#23707), deemed
the study exempt for research purposes.
Study population

The OAI study sample consisted of subjects of both
sexes and of all ethnicities aged 45–79 years. All subjects
were classified at baseline according to one of three subgroups: clinically significant knee osteoarthritis at risk of
disease progression (progression); subjects at high risk of
developing clinically significant knee OA (incident); and
a control group. The progression subgroup patients
complained of frequent knee symptoms or radiographic
tibiofemoral knee OA in at least one native knee. The
incident cohort was free of baseline symptomatic knee
OA, but had established risk factors including the presence of heberden’s nodes in both hands, increased weight;
previous knee operation; previous knee injury; family history; and pain in the knee on most days of the preceding
month. The control group did not have pain nor radiographic findings or risk factors.
We identified 2,585 subjects aged ≥ 60 years and excluded subjects with missing measures of adiposity (body
mass index [BMI] (n = 1) or waist circumference [WC]
(n = 38)); BMI <18.5 kg/m2 (n = 4), and those dead at
follow-up (n = 166). We excluded subjects without baseline primary outcome measures (short-form 12 (n = 21)
or physical activity scores (n = 15)). Subjects with incident
total knee arthroplasty (n = 158) were also excluded to
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allow the ascertainment of the natural history of osteoarthritis in the absence of surgical intervention for the
knee. The final cohort consisted of 2,182 subjects.
Study measures

All study-related data was obtained by patient selfreport or by measurements based on study protocols.
Questionnaires collected data on baseline demographic,
medical, social and ethnic characteristics of subjects.
Age at the initial visit was considered age at baseline.
We dichotomized marital status as ‘married’ or ‘single’,
with the latter consisting of widow, divorced, separated
or never married. Education status was classified as follows: high school (graduated or not); attended college;
college graduate; graduate level. Ever smokers were considered patients who smoked >100 cigarettes in their life.
The Western Ontario and McMaster University OA
Index (WOMAC) Pain Scale was utilized to assess selfreported knee pain on a 5-point Likert scale. Pain scores
ranged from 0–20 with higher scores representing worse
symptoms. Subjects with knee osteoarthritis on x-ray
were considered to have knee OA. The Charlson comorbidity index captured the degree of medical comorbidity in the cohort. Subjects were classified as having an impairment in an activity of daily living if they
were unable to perform any of the following: dressing,
walking, bathing, eating, getting out of bed, or toileting.
Measurements

Participant weight was measured without shoes or heavy
jewelry, wearing light clothing, using a calibrated standard balance beam scale. Standing height was measured
with a wall-mounted stadiometer. Waist circumference
was measured at the level of the umbilicus between the
lower rib and the iliac crest. BMI was calculated as
weight (in kilograms) divided by height (in meters)
squared. Gait speed was measured using the 20 m walk
test, a validated measure of functional status in people
with knee osteoarthritis [16]. Participants walked 20 m
in an unobstructed corridor at their usual walking speed
and were timed. Reliability and intra-class correlations
ranged from 0.93 to 0.98 within and between testers in
patients with moderate to severe knee OA.
Outcome measures

The Short-Form 12 (SF12) is a self-reported valid and
reliable measure of a person’s perceived health status
[17]. The overall score accounts for >90% of the statistical variance of the longer Short Form 36 scale [18],
and is valid, reliable and easily self-administered Physical
and mental component scores are assessed on a Likert
scale, and overall SF-12 score combines the two assessments. Overall scores range from 0 to 100 and was
administered as a take-home questionnaire.
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The Physical Activity Scale for the Elderly (PASE) [19]
is a measure of occupational, household, and leisure
activities during a one-week period in older adults
>65 years. This 26-item instrument is reliable and valid,
and can be administered by telephone, mail or be administered in-person. In this study, the scale was administered in person. The general population has a mean
score of 103 ± 64.1, with greater scores indicating greater
intensity of activity. However, no known minimally clinically important differences are available.
The validated Late-Life Function and Disability Instrument (LLDI) [20] focuses on functional limitations and
frequency limitations. These domains parallel Nagi’s
disablement framework [21] on disability in communitydwelling adults. Functional limitations reflect a person’s
inability to perform daily activities, while frequency limitations characterize the inability to engage in social environments and major life tasks. Higher scores indicate higher
levels of function and is scored on a 0–100 scale. The scale
corresponds to both the physical functioning subscale of
the SF-36 and London Handicap Scale [22].
Statistical analysis

All data are represented as either means ± standard deviation, or counts (percent) (Table 1). The cohort was stratified by waist circumference quartiles [<95.1, 95.1-103.2,
103.2-111, 111–149.3 cm] Baseline characteristics across
groups were compared using chi square and one-way
ANOVA tests. We used paired t-tests to compare baseline
to six year follow-up data (Table 2). To determine the
association of baseline WC on functional outcomes at
six years we used multiple linear regression. The primary six-year outcomes of interest included SF-12,
PASE score, and LLDI scoring. Our primary predictor
was WC using quartiles (referent = lowest quartile). As
differences may be introduced simply because categories
reflect different points in the distribution, researchers
often control for this effect by dividing variables into categories of equal size [23]. Three separate regression analyses were performed. We determined the mean follow-up
scores for each functional outcome in each of the WC
categories after adjusting for age, sex, education level,
race, cohort type (incident, progression and control),
Charlson co-morbidity score [24], current smoking status, and adjusting for baseline scores where available
(Tables 3 and 4). As many indicator variables are associated with both obesity and our outcome measures, we
adjusted in our analysis for a modified Charlson index
including chronic obstructive pulmonary disease, ulcers,
renal disorders, kidney transplant, rheumatoid arthritis,
and cancer Tables 5 and 6. Other variables excluded
from this composite score included subjects that had
not fulfilled criteria for these at baseline. Second, we
stratified our cohort by age, as disability is known to
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Table 1 Baseline Characteristics of all subjects >60 years old (n = 2,182)

Age, years

Waist circumference

Quartile

Overall cohort

Low

25-50%

50-75%

75%+

N = 2,182

n = 553

n = 538

n = 548

n = 543

p-value

68.2 ± 5.4

67.9 ± 5.4

68.7 ± 5.4

68.5 ± 5.4

67.5 ± 5.3

<0.001

1367 (62.7)

390 (70.5)

326 (60.6)

327 (59.7)

324 (59.7)

<0.001

< High School

432 (19.8)

93 ( 16.8)

111 (20.6)

119 (21.7)

109 (20.1)

Some College

524 (24.0)

125 (22.6)

134 (24.9)

128 (23.4)

137 (25.2)

College

417 (19.1)

103 (18.6)

101 (18.7)

99 (18.1)

114 (21.0

>College

809 (37.1)

232 (42.0)

192 (35.7)

202 (36.9)

183 (33.7)

1115 (53.7)

301 (57.0)

280 (55.2)

285 (54.7)

249 (47.8)

0.02

1443 (66.2)

370 (67.0)

368 (68.4)

376 (68.6)

329 (60.6)

0.02

White

1792 (82.2 )

473 (85.7)

434 (80.7)

451 (82.3)

434 (79.9)

Black

336 (15.4)

62 (11.2)

90 (16.7)

85 (15.5)

99 (18.2)

Female Sex, %
Education Status

0.23

Yearly Income
>$50,000
Marital Status
Married
Race

0.003

53 (2.4)

9 (1.6)

8 (1.5)

2 (0.4)

–

Charlson Score

0.45 ± 0.9

0.31 ± 0.73

0.45 ± 0.89

0.48 ± 0.96

0.58 ± 0.99

Modified Charlson Score

0.09 ± 0.30

0.05 ± 0.21

0.09 ± 0.31

0.12 ± 0.23

0.12 ± 0.34

<0.001

WOMAC pain Right

16.0 ± 15.5

8.4 ± 11.9

10.8 ± 13.4

12.3 ± 14.3

14.2 ± 15.3

<0.001

Asian

<0.001

WOMAC pain Left

16.4 ± 16.8

7.8 ± 12.6

10.8 ± 14.6

12.0 ± 15.3

13.8 ± 16.1

<0.001

Ever Smoker

1084 (50.1)

258 (46.8)

256 (48.1)

289 (53.1)

281 (52.2)

0.10

# Medications

3.83 ± 2.44

3.41 ± 2.27

3.61 ± 2.30

3.99 ± 2.49

4.27 ± 2.59

<0.001

Knee Osteoarthritis Present

1315 (60.3)

269 (48.6)

324 (60.2)

341 (62.2)

381 (70.2)

<0.001

Waist circumference, cm

103.2 ± 12.1

88.4 ± 5.9

98.9 ± 2.2

106.7 ± 2.3

118.7 ± 6.8

<0.001

Body Mass Index, kg/m2

28.3 ± 4.5

24.1 ± 2.9

26.9 ± 3.0

29.2 ± 2.9

33.2 ± 3.4

<0.001

1,595 (73.1)

453 (81.9)

401 (74.5)

397 (72.5)

344 (63.4)

577 (26.4)

96 (17.4)

133 (24.7)

150 (27.4)

198 (36.5)

10 (0.5)

4 (0.7)

4 (0.7)

1 (0.2)

1 (0.2)

Cohort Allocation
Incident
Progression
Control

<0.001

All values represent mean ± SD, or count (%).
P-value represents the ANOVA across all waist circumference quartiles categories.
Abbreviations: OA defined as having radiographic knee osteoarthritis on either knee or both knees, WOMAC Western Ontario and McMaster University
Arthritis Index.
Some fields may not add up to overall cohort totals due to missing values.
Modified Charlson score consisted of the following variables: chronic obstructive pulmonary disease, ulcers, renal disorders, kidney transplant, rheumatoid arthritis,
and cancer.

change with advanced age. Separate analyses were performed on the 60–70 year age group and the ≥ 70 year
age group. Third, we stratified our analyses by knee
osteoarthritis (present/absent). We performed inverse
probability weighting to account for missing outcome
data at follow-up. Adjusted means (95% confidence intervals), or mean differences compared to the lowest
WC quartile are presented. Body weight and body mass
index were highly collinear and hence were not included
in our modeling. We present the R2 of models using
standard BMI categories and WC quartiles in Table 7.

All estimates were calculated using STATA version 12
(STATACorp, College Station, TX). A p value of <0.05
was considered statistically significant.

Results
Statistical differences were observed in age, although
there was a higher proportion of females in the low WC
quartile (Table 1). Charlson co-morbidity score and its
modified version, WOMAC scores, and number of medications increased with increasing WC quartile. The proportion of subjects with knee OA increased by quartile.
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Table 2 Primary and follow-up outcome measures – unadjusted quartiles (n = 2,182)
Waist circumference

Quartile

e

Overall cohort

low

25-50%

50-75%

75%+

p-value

Baseline

103.5 ± 11.1

106.0 ± 9.9

104.3 ± 10.7

102.3 ± 11.6

101.2 ± 11.3

<0.001

Follow-up

101.1 ± 12.4

103.9 ± 11.3

102.4 ± 12.3

99.4 ± 12.7

98.5 ± 12.7

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

Baseline

48.7 ± 8.9

51.3 ± 7.9

49.4 ± 8.7

47.7 ± 9.3

46.5 ± 9.11

<0.001

Follow-up

46.4 ± 9.7

49.0 ± 8.8

47.4 ± 9.7

45.0 ± 9.7

44.0 ± 10.0

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

Baseline

54.8 ± 7.5

54.8

54.9

54.6

54.7

0.90

Follow-up

54.7 ± 8.1

54.9 ± 7.5

55.0 ± 7.5

54.4 ± 8.6

54.5 ± 8.9

0.63

0.21

0.71

0.89

0.43

0.23

Baseline

136.4 ± 67.2

146.9 ± 68.3

139.4 ± 68.2

130.7 ± 67.0

128.8 ± 63.8

<0.001

Follow-up

123.7 ± 64.7

133.1 ± 64.2

125.3 ± 63.5

126.8 ± 68.2

108.4 ± 58.7

<0.001

<0.001

<.001

<0.001

0.01

<0.001

Frequency

55.3 ± 6.3

56.2 ± 6.3

54.9 ± 6.1

55.0 ± 6.4

54.9 ± 6.3

0.004

Limitation

80.9 ± 15.3

83.6 ± 15.0

82.3 ± 15.2

79.4 ± 15.2

78.3 ± 15.2

<0.001

ADL Impairment

172 (10.6)

31 (7.3)

36 (8.9)

42 (10.4)

63 (16.6)

<0.001

Baseline

1.29 ± 0.21

1.34 ± 0.22

1.32 ± 0.22

1.27 ± 0.20

1.23 ± 0.20

<0.001

Follow-up

1.24 ± 0.21

1.30 ± 0.21

1.25 ± 0.22

1.23 ± 0.19

1.16 ± 0.21

<0.001

<0.001

<0.001

<0.001

<0.001

<0.001

SF-12 Score
Total

p-value
Physical

p-value
Mental

p-value
PASE

p-value
LLDI

Gait Speed

p-value

All values represent mean ± SD, or count (%).
P-value represents the difference between the excluded and included analytical cohort.
Abbreviations: ADL Activities of Daily Living, LLDI Late-life disability index, PASE Physical Activity Scale for the Elderly, SF- Short Form.

Comparing subjects included in our analysis to those excluded demonstrated that those excluded (either having
a knee arthroplasty or have died) were older, less likely
to be female, and have higher comorbidity scores and
number of medications. They had lower SF-12 scores at
baseline but no differences in PASE scores [Data not
shown]. Notably there was high correlation between
body mass index and waist circumference (r = 0.79).
The unadjusted functional outcome data are presented
in Table 2. Outcomes are compared between WC groups
at baseline and six years and outcomes are compared
across time in each group. Overall and physical component scales of the SF-12 dropped with increasing waist
circumference both at baseline and follow-up, and
dropped significantly within each category between baseline and follow-up. Mental component scores did not
change. There were marked parallel declines in PASE
scores over time and between groups at each baseline

and 6 years follow-up. LLDI scores diminished at followup and the proportion of ADL impairments increased
significantly from 18.0% in the lowest WC quartile to
36.6% in the upper WC quartile.
Our multivariable regression models are presented in
Table 3 (overall scores and stratified by age) and Table 4
(stratified by OA status). In examining by WC quartile,
SF-12 decline appears to be age-dependent and subjects
in the high WC quartile had markedly lower scores than
the lowest quartile. High WC quartile subjects had significant declines in PASE scores as compared to the
other categories but only in the ≥70 year age group. The
limitation component of the LLDI was most impacted in
the ≥70 year age group as compared to the low WC
quartile. Lastly, gait speed was lowest in the highest WC
quartile as compared to the other categories. Generally,
the adjusted estimates were similar adjusting for either the
Charlson score or the modified Charlson co-morbidity
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Table 3 Multivariable regression analysis of follow-up primary outcome measures (n = 2,182)
Waist

Circumference

Quartile

Low WC

25-50%ile

50-75%ile

75%+

Overall

102.4 [101.0-103.9]

102.7 [101.5-103.9]

101.7 [100.7-102.8]

100.5 [99.2-101.8]

Δ

---

0.28

−0.69

−1.92 (p = 0.04)

60-70

102.9 [101.0-104.9]

103.0 [101.3-104.8]

102.5 [101.2-103.9]

101.4 [99.8-103.1]

Δ

---

0.10

−0.46

−1.50

70+

101.5 [99.0-104.0

102.1 [100.3-104.0]

100.3 [98.5-102.1]

99.1 [96.9-101.2]

Δ

---

0.62

−1.22

−2.45

Overall

47.9 [46.9-48.8]

47.6 [46.7-48.5]

46.7 [45.8-47.5]

45.5 [44.5-46.0]

Δ

---

−0.26

−1.20

−2.3 (p = 0.001)

60-70

47.8 [46.6-49.1]

48.7 [47.5-49.8]

47.0 [45.8-48.2]

46.2 [44.9-47.6]

Δ

---

0.83

−0.85

−1.61

70+

47.7 [46.0-49.4]

46.4 [45.0-47.9]

46.2 [44.9-47.5]

44.4 [42.9-46.0]

Δ

---

−1.26

−1.54

−3.26 (p = 0.004)

Overall

55.2 (54.4-55.9)

55.3 (54.5-56.1)

54.9 (54.2-55.7)

54.7 (53.8-55.5)

Δ

---

−0.39

0.16

−0.40

60-70

55.3 (54.3-56.2)

54.9 (53.8-55.9)

55.4 (54.5-56.4)

54.9 (53.8-56.0)

Δ

---

−0.39

0.16

−0.40

70+

54.9 (53.6-56.2)

55.6 (54.4-56.8)

54.3 (53.0-55.0)

54.5 (53.1-55.9)

Δ

---

0.71

−0.60

−0.37

Overall

131.0 (124.3-137.7)

126.6 (120.3-132.8)

128.7 (121.5-135.9)

109.6 (102.6-116.6)

Δ

---

−4.47

−2.34

−21.4 (p < 0.001)

60-70

137.4 (127.8-146.9)

136.4 (12.7-145.1)

136.4 (126.7-146.2)

119.9 (111.1-128.7)

Δ

---

−1.0

−0.97

−17.5 (p = 0.006)

70+

117.5 (109.5-125.5)

112.2 (103.4-121.0)

114.6 (105.3-124.0)

93.5 (82.8-104.0)

Δ

---

−5.2

−2.83

−23.9 (p < 0.001)

Overall

56.0 (55.3-56.7)

55.6 (54.9-56.2)

55.9 (55.2-56.5)

55.1 (54.4-55.8)

Short-Form 12 Score
Overall Score

Physical

Mental

Physical Activity Scale for Elderly

Late-Life Disability Index
Frequency

Limitation

Gait Speed

Δ

---

−0.43

−0.17

−0.94

60-70

56.7 (55.8-57.6)

56.1 (55.1-57.0)

56.1 (55.2-57.8)

55.7 (54.8-56.6)

Δ

---

−0.66

−0.61

−1.1

70+

55.0 (54.0-56.0)

54.8 (53.9-55.8)

55.4 (54.4-56.5)

54.1 (53.0-55.2)

Δ

--

−0.20

0.43

−0.90

Overall

83.3 (81.6-84.9)

83.2 (81.6-84.8)

81.8 (80.3-83.3)

79.2 (77.5-81.0)

Δ

--

−0.07

−1.47

−4.05 (p = 0.001)

60-70

84.2 (82.1-86.4)

84.6 (82.4-86.8)

83.2 (81.2-85.1)

80.9 (78.9-82.9)

Δ

--

0.38

−1.06

−3.3 (p = 0.026)

70+

81.8 (79.3-84.4)

81.1 (78.6-83.5)

80.0 (77.6-82.4)

76.3 (73.1-79.4)

Δ

---

−0.77

−1.86

−5.56 (p = 0.006)

Overall

1.28 (1.26-1.31)

1.25 (1.23-1.27)

1.25 (1.23-1.26)

1.19 (1.17-1.22)

Δ

---

−0.03 (p = 0.018)

−0.04 (p = 0.06)

−0.09 (p < 0.001)

60-70

1.29 (1.26-1.32)

1.28 (1.25-1.31)

1.27 (1.24-1.29)

1.24 (1.21-1.27)
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Table 3 Multivariable regression analysis of follow-up primary outcome measures (n = 2,182) (Continued)
Δ

---

−0.02

−0.02

0.05 (p = 0.009)

70+

1.27 (1.23-1.31)

1.19 (1.15-1.23)

1.21 (1.17-1.24)

1.11 (1.07-1.16)

Δ

--

−0.08 (p = 0.002)

−0.06 (p = 0.015)

−0.15 (p < 0.001)

Values represent mean score (95% confidence interval) of the indicated metric adjusted for: Age, sex, education level, race, modified Charlson co-morbidity index,
smoking status, knee OA, hip pain and cohort type (incident, progression or control), and baseline scoring (SF-12, PASE) where available. Values in 25-50%,
50-75%, high WC quartile columns represent difference from referent category (low WC). Models stratified by age adjust for the similar co-variates other than age.
Modified Charlson score consists of the following variables: chronic obstructive pulmonary disease, ulcers, renal disorders, kidney transplant, rheumatoid arthritis,
and cancer.

Table 4 Multivariable regression analysis of follow-up primary outcome measures (n = 2182)
Waist

Circumference

Quartile

Low WC

25-50% WC

50-75% WC

75%+

100.1 [97.6-102.6]

101.2 [99.6-102.9]

100.4 [99.0-101.7]

99.9 [98.3-101.4]

Short-Form 12 Score
Overall Score

OA +
Δ
OA Δ

Physical

OA +
Δ
OA Δ

Mental

OA +
Δ
OA Δ

Physical Activity Scale for Elderly

OA +
Δ
OA Δ

---

1.18

0.32

−0.19

105.6 [104.4-106.9]

105.0 [103.3-106.7]

104.3 [102.6-105.9]

101.9 [99.7-104.0]

---

−0.63

−1.37

−3.77 (p = 0.002)

47.0 [45.7-48.2]

46.2 [45.1-47.4]

45.1 [43.9-46.2]

44.5 [43.2-45.7]

---

−0.71

−1.90 (p = 0.02)

−2.50 (p = 0.003)

50.2 [49.0-51.4]

49.9 [48.4-51.3]

49.8 [48.6-51.0]

47.6 [45.9-49.3]

---

−0.33

−0.38

−2.60

54.9 [53.9-55.9]

55.1 [54.0-56.2]

55.2 [54.2-56.3]

55.5 [54.5-56.5]

---

0.16

0.33

0.57

55.3 [54.3-56.4]

55.4 [54.4-56.5]

54.4 [53.2-55.5]

53.0 [51.4-54.6]

---

0.09

−0.93

−2.21 (p = 0.015)

128.2 [119.3-137.2]

121.0 [113.7-128.3]

128.5 [119.7-137.4]

107.8 [99.6-116.0]

---

−7.3

0.31

−20.4 (p < 0.001)

137.5 [128.1-146.9]

136.5 [125.1-147.9]

129.8 [117.7-141.9]

111.7 [99.6-123.8]

---

−1.0

−7.7

−25.8 (p = 0.001)

55.7 [54.8-56.6]

55.4 [54.6-56.3]

55.1 [54.4-55.9]

54.9 [54.1-55.7]

---

−0.28

−0.59

−0.84

56.8 [55.9-57.7]

55.7 [54.6-56.8]

57.2 [55.9-58.4]

55.4 [54.1-56.8]

---

−1.10

0.36

−1.38

82.0 [79.9-84.2]

81.8 [79.7-83.9]

81.3 [79.4-83.1]

79.0 [76.9-81.0]

---

−0.18

−2.37

−6.12 (p = 0.002)

85.6 [83.6-87.7]

85.5 [82.9-88.0]

83.3 [80.8-85.8]

79.5 [76.2-82.9]

---

−0.22

−0.79

−3.08 (p = 0.04)

Late-Life Disability Index
Frequency

OA +
Δ
OA Δ

Limitation

OA +
Δ
OA Δ

Gait Speed

OA +
Δ
OA Δ

1.27 [1.24-1.30]

1.23 [1.20-1.26]

1.23 [1.21-1.25]

1.18 [1.15-1.21]

---

−0.04 (p = 0.04)

−0.04 (p = 0.017)

−0.09 (p < 0.01)

1.32 [1.29-1.34]

1.28 [1.25-1.31]

1.28 [1.24-1.31]

1.21 [1.17-1.25]

---

−0.03

−0.036

−0.11 (p < 0.001)

Δ – represents the adjusted difference between each tertile of Waist Circumference (WC) and low WC.
Models were adjusted for age, sex, race, education, Charlson co-morbidity index, smoking status, and cohort type. Baseline scores were included where available.
Modified Charlson score consisted of the following variables: chronic obstructive pulmonary disease, ulcers, renal disorders, kidney transplant, rheumatoid arthritis,
and cancer.

Batsis et al. Nutrition Journal 2014, 13:81
http://www.nutritionj.com/content/13/1/81

Page 8 of 13

Table 5 Multivariable Regression Analysis of Follow-up Primary Outcome Measures (n=2,182) – Using Charlson
Co-Morbidity Index as a Co-Variate
Waist

Circumference

Quartile

Low WC

25-50%ile

50-75%ile

75%+

Overall

100.4 [98.3-102.5]

101.8 [100.7-102.8]

100.4 [99.4-101.4]

99.9 [98.8-101.0]

Δ

---

1.39

-0.02

-0.53

60-70

99.5 [95.1-103.8]

102.4 [101.0-103.9]

101.5 [100.2-102.7]

100.9 [99.6-102.2]

Δ

--

2.96

2.00

1.43

70+

100.7 [98.5-102.8]

100.8 [99.2-102.3]

98.5 [96.8-100.2]

98.2 [96.3-100.0]

Δ

--

0.08

-2.18

-2.53 (p=0.05)

Overall

46.8 [45.5-48.0]

46.8 [46.0-47.6]

45.6 [44.8-46.5]

45.2 [44.3-46.0]

Δ

---

0.02

-1.13

-1.60*

60-70

45.9 [43.5-48.3]

47.8 [46.7-48.9]

46.2 [45.1-47.3]

45.9 [44.7-47.1]

Δ

--

1.90

0.27

-0.02

70+

47.2 [45.7-48.7]

45.4 [44.1-46.7]

44.8 [43.5-46.1]

43.8 [42.4-45.1]

Δ

---

-1.84 (p=0.05)

-2.40 (p=0.015)

-3.47*

Overall

54.6 [53.7-55.4]

55.1 [54.4-55.8]

54.5 [53.8-55.2]

54.5 [53.7-55.3]

Δ

---

0.53

-0.02

-0.06

60-70

54.4 [53.0-55.8]

55.0 [54.1-55.9]

55.2 [54.3-56.0]

54.8 [53.8-55.8]

Δ

---

0.56

0.79

0.38

70+

54.5 [53.4-55.6]

55.2 [54.2-56.2]

53.5 [52.3-54.6]

54.4 [53.2-55.6]

Δ

---

0.70

-1.06

-0.14

Overall

127.2 [121.2-133.2]

125.2 [119.8-130.6]

127.8 [121.5-134.1]

110.7 [104.7-116.6]

Δ

---

-2.04

0.55

-16.6*

60-70

132.6 [124.0-141.2]

136.7 [129.2-144.2]

136.3 [127.6-144.9]

122.5 [114.7-130.3]

Δ

---

3.09

3.67

-10.1

70+

116.4 [108.9-124.0]

108.6 [101.1-116.2]

113.6 [105.2-122.1]

93.2 [84.2-102.2]

Δ

---

-7.80

-2.80

-23.2*

Overall

55.5 [54.8-56.1]

55.1 [54.5-55.6]

55.3 [54.7-55.8]

55.1 [54.4-55.7]

Short-Form 12 Score
Overall Score

Physical

Mental

Physical Activity Scale for Elderly

Late-Life Disability Index
Frequency

Limitation

Gait Speed

Δ

---

-0.44

-0.25

-0.46

60-70

56.0 [55.1-56.9]

55.6 [54.8-56.4]

55.7 [54.9-56.5]

55.6 [54.8-56.4]

54.3 [53.5-55.5]

54.5 [53.6-55.5]

54.2 [53.2-55.2]

Δ

---

70+

54.7 [53.8-55.7]

Δ

--

-0.40

-0.28

-0.40

Overall

82.2 [80.6-83.8]

82.3 [80.8-83.6]

79.6 [78.2-81.0] (p=0.02)

78.8 [77.3-80.3] (p=0.002)

Δ

---

0.05

-2.60

-3.4

60-70

83.0 [80.5-85.4]

83.9 [82.0-85.8]

81.0 [79.2-82.9]

80.5 [78.7-82.3]

Δ

---

0.97

-1.91

-2.42

70+

81.3 [78.9-83.6]

79.6 [77.4-81.7]

77.6 [75.4-79.8]

76.1 [73.5-78.7]

Δ

---

-1.70

-3.68 (p=0.02)

-5.16 (p=0.03)

Overall

1.25 [1.22-1.29]

1.24 [1.22-1.26]

1.23 [1.22-1.25]

1.19 [1.17-1.21]

Δ

---

0.02

-0.02

-0.07*

60-70

1.25 [1.18-1.33]

1.27 [1.25-1.30]

1.26 [1.24-1.28]

1.23 [1.21-1.26]
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Table 5 Multivariable Regression Analysis of Follow-up Primary Outcome Measures (n=2,182) – Using Charlson
Co-Morbidity Index as a Co-Variate (Continued)
Δ

---

0.02

0.04

-0.02

70+

1.23 [1.20-1.26]

1.18 [1.15-1.21]

1.19 [1.16-1.22]

1.12 [1.08-1.15]

Δ

---

-0.05 (p=0.019)

-0.04 (p=0.05)

-0.11*

Values represent mean score (95% confidence interval) of the indicated metric adjusted for: Age, sex, education level, race, Charlson co-morbidity index, smoking
status, knee OA, hip pain and cohort type (incident, progression or control), and baseline scoring (SF-12, PASE) where available. Values in 25-50%, 50-75%, high
WC quartile columns represent difference from referent category (low WC). Models stratified by age adjust for the similar co-variates other than age.

Table 6 Multivariable Regression Analysis of Follow-up Primary Outcome Measures (n=2182) – Using Charlson
Co-Morbidity Index as a Co-Variate
Waist

Circumference

Quartile

Low WC

25-50% WC

50-75% WC

75%+

97.3 [93.4-101.2]

100.9 [99.5-102.2]

99.1 [97.8-100.4]

98.9 [97.6-100.2]

Short-Form 12 Score
Overall Score

OA +
Δ
OA Δ

Physical

OA +
Δ
OA Δ

Mental

OA +
Δ
OA Δ

Physical Activity Scale for Elderly

OA +
Δ
OA Δ

---

3.53

1.74

1.60

104.1 [102.7-105.4]

103.3 [101.7-104.8]

102.7 [101.1-104.3]

101.7 [99.8-103.6]

---

-0.78

-1.35

-2.4 (p=0.03)

45.4 [43.6-47.2]

45.6 [44.5-46.6]

44.1 [43.0-45.2]

44.0 [42.9-45.0]

---

-0.29

-0.85

-1.74

49.2 [48.0]

48.9 [47.6-50.2]

48.3 [46.9-49.7]

47.4 [46.0-48.9]

--

0.16

-1.32

-1.41

54.1 [52.7-55.4]

55.3 [54.3-56.2]

54.8 [53.9-55.8]

54.9 [53.9-55.8]

---

1.19

0.77

0.80

54.9 [54.0-55.9]

54.5 [53.6-55.5]

54.2 [53.1-55.2]

53.8 [52.5-55.1]

----

-0.39

-0.77

-1.15

124.7 [116.6-132.8]

120.7 [114.4-127.0]

126.7 [119.0-132.3]

109.2 [101.9-116.5]

--

-3.95

1.99

-15.5 (p=0.004)

132.0 [126.6-140.4]

133.4 [123.4-143.5]

128.3 [117.1-139.4]

112.7 [102.9-122.5]

--

1.42

-3.74

-19.3 (p=0.003)

55.1 [54.2-56.0]

55.0 [54.3-55.7]

54.7 [54.1-55.4]

54.6 [53.9-55.4]

--

-0.10

-0.38

-0.47

56.2 [55.4-57.1]

55.0 [54.1-55.9]

56.3 [55.1-57.4]

55.8 [54.6-57.0]

--

-1.22 (p=0.05)

0.02

-0.41

80.7 [78.4-83.0]

81.3 [79.5-83.1]

79.3 [77.6-81.0]

78.2 [76.4-79.9]

---

0.60

-1.38

-2.55

84.0 [82.0-86.0]

83.9 [81.5-86.2]

80.5 [77.8-83.2]

79.9 [77.1-82.7]

---

-0.12

-3.49 (p=0.04)

-4.10 (p=0.02)

1.23 [1.17-1.29]

1.22 [1.19-1.24]

1.22 [1.20-1.24]

1.17 [1.15-1.19]

-0.02

-0.01

-0.06 (p=0.046)

1.29 [1.27-1.31]

1.27 [1.24-1.30]

1.26 [1.23-1.29

1.21 [1.18-1.24]

---

-0.02

-0.03

-0.08*

Late-Life Disability Index
Frequency

OA +
Δ
OA Δ

Limitation

OA +
Δ
OA Δ

Gait Speed

OA +
Δ
OA Δ

Δ – represents the adjusted difference between each tertile of Waist Circumference (WC) and low WC. Models were adjusted for age, sex, race, education,
Charlson co-morbidity index, smoking status, and cohort type. Baseline scores were included where available.
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Table 7 R2 of Multivariable waist circumference or body mass index modeling
R2 of model with

Charlson index

R2 of model with

Waist circumference

Body mass index

Waist circumference

Modified charlson index
Body mass index

Short-Form 12 Score
Overall Score

Physical

Mental

Physical Activity Scale for
Elderly

Overall

0.4011

0.4054

0.3879

0.3943

60-70

0.407

0.3894

0.3876

0.3971

70+

0.41352

0.902

0.3902

0.3931

Overall

0.3147

0.3187

0.3171

0.3194

60-70

0.3154

0.3210

0.3104

0.3146

70+

0.3102

0.3093

0.3274

0.3236

Overall

0.2308

0.2313

0.2065

0.2094

60-70

0.225

0.2258

0.2089

0.2126

70+

0.2591

0.2564

0.2233

0.2226

Overall

0.2443

0.2425

0.2606

0.2576

60-70

0.2132

0.2019

0.2298

0.2306

70+

0.2284

0.2181

0.2550

0.2444

Overall

0.1022

0.1022

0.0866

0.0881

60-70

0.0967

0.0969

0.0849

0.0881

70+

0.1006

0.1007

0.0709

0.0962

Overall

0.0936

0.0916

0.0912

0.913

60-70

0.0987

0.0983

0.101

0.107

Late-Life Disability Index
Frequency

Limitation

Gait Speed

70+

0.0754

0.0711

0.0873

0.0820

Overall

0.5377

0.05342

0.5277

0.5226

60-70

0.5019

0.4998

0.4921

0.4911

70+

0.5469

0.5382

0.5528

0.5368

All models adjust for age, sex, education level, race, smoking status, knee OA, hip pain and cohort type (incident, progression or control), and baseline scoring
(SF-12, PASE) where available. Standard Charlson Co-morbidity Index is accounted for in the R2 in the first two columns, while a modified Charlson Co-morbidity
index accounting for Chronic Obstructive Pulmonary Disease, Peptic Ulcer Disease, Kidney Disease, Kidney Transplant, Rheumatoid Arthritis and
Polymyalgia Rheumatica.

index (Table 5). Patients with osteoarthritis generally had
lower outcome measures as compared to those without
OA (Table 6). However, significant differences were observed in PASE scores in both cohorts, yet only those
without OA had differences compared to the low WC
quartile for the limitation domain of the LLDI and gait
speed. Model R2 were similar for predictor variables for
both WC and BMI (Table 7).

Discussion
Older adults with high waist circumference are at risk
for reduced self-reported health, physical activity scores,
and disability. Our results also suggest that the presence
of OA leads to markedly reduced quality of life and
physical activity scores than in subjects without OA in
those with elevated visceral adiposity.
Elevated waist circumference has been associated with
progression of OA in both cross-sectional and longitudinal
epidemiological studies [25,26]. Our study specifically
targets the association of WC with geriatric outcomes,

including disability, quality of life and physical activity
that have not been adequately evaluated longitudinally.
Previous findings have demonstrated inconsistent relationships between WC and functional decline in older
adults [27,28]. Yet, our results are consistent with those
[29] who demonstrated that the highest WC quartile
was associated with mobility and agility disability in an
older cohort at 2-year follow-up. We found robust relationships between visceral obesity with respect to degree of functional impairment elderly persons over time
suggesting a compelling rationale for clinician encouragement of weight reduction targeting visceral or central obesity in older adults at risk for osteoarthritis.
We found that after stratification by OA status, physical component scores of the SF-12, PASE score, and
LLDI scores were consistently lower in those with OA.
Additionally, gait speed was lower in this cohort. These
results are not surprising but the differences between
high WC quartile and lowest appeared to be present
only in those without OA. These findings suggest that
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the rate of decline between WC quartiles likely has plateaued well before the development of OA. While purely
hypothesis generating, this data could suggest the importance of identifying visceral adiposity in a population
at risk knee OA population. Providers should consider
promote weight loss to delay physical disability in this
population.
Our findings underscore the importance of visceral
adiposity measured by easily obtained clinical variables
as an important and easily obtained metric with significant predictive value in long-term outcomes for older
adults at risk for osteoarthritis. Yet caution is warranted
in interpreting our results that may underestimate the
natural history of decline observed. First, our cohort was
relatively young (mean was ~68 years). The onset of disability increases with increasing age [1] and hence longer
follow-up may be needed to delineate the natural course
of the obesity in relation to OA. Frailty and disability
often are preceded by years of preserved or compensated
functional decline which would not be reflected in our
findings. Second, the recruitment was based on a
community-based cohort who would be able to participate in this clinical trial and may not be fully representative of the general population of older adults in the
community. Third, the degree of co-morbidity was quite
modest in the study population, implying a healthier
population. While these results provide a reasonable
basis for future study of important longitudinal geriatric
outcomes, the magnitude of our changes are modest and
may not necessarily be clinically significant. A longer
follow-up with a cohort with advanced medical and
sociodemographic characteristics would be required to
confirm our results in a more medically and functionally
compromised population of older adults. Lastly, WC
quartiles as our main predictor was in line with previous
author’s recommendations that it facilitates comparison
of anthropometric indices between studies [23]. Incorporating WC as a continuous variable would require
polynomial regression modeling, which would lead to
challenges with interpretability of our results from a
clinical standpoint.
We acknowledge a number of other limitations in our
study. While the dataset was designed to observe longitudinal outcomes specific to OA, our analysis may not
have coincided with the primary scope of the initial
study design. Additionally, of those aged 60 or greater,
we were missing data on a number of distal (six-year)
outcomes. While we attempted to mitigate this issue by
comparing included subjects vs. non-included subjects,
and used a statistical methodology to account for such
issues, our missing cohort appeared to have higher degree
of comorbidity and socioeconomic status, suggesting that
our results may indeed be an underestimate of the true
effect observed. Importantly, our analysis differed from
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one published by Colbert et al. [30], who utilized the
OAI and its four-year outcomes to assess the impact of
obesity and race on gait speed and WOMAC scores
[31]. Although our data was consistent with theirs,
these authors did not specifically look at older adults,
nor did they utilize PASE, SF-12 or LLDI as primary
outcomes. Our results are at risk for possible overadjustment as well. We deliberately presented unadjusted
data to demonstrate the similar trends after accounting
for a priori variables that we believed could impact our estimates. We agree that certain variables including social
support, depression, and physical measures could conceivably have been omitted and/or excluded in our analysis.
To account for possible confounding between predictor
variables in the Charlson index, we restricted our modified
index to those factors likely not influenced by obesity or
disability outcomes. Although the estimates were slightly
different, the trends were not. Lastly, future studies should
relate anthropometric with body composition measures
and distal outcomes.
BMI fails to differentiate between central and peripheral
fat stores [8]. These results focus solely on the impact of
central adiposity on functional outcomes in older adults.
We previously demonstrated in a similar population that
BMI impacts quality of life and physical function [Batsis
et al. Under Review, Public Health Nutrition], and this
current study suggests that abdominal obesity could be a
separate predictor of poor functional outcomes. Our intent in this study was not to differentiate which anthropometric measures is superior in predicting distal outcomes.
We were unable to adjust for BMI in our modeling as the
two variables were highly collinear. This was not surprising in this sample as study recruitment focused on those
with risk factors for OA (including overweight and obese
based on BMI) making the metrics more homogenous.
We believe that future studies should consider not only
the impact of elevated WC in normal BMI individuals, but
the corollary to identify the potential contribution of each
metric. Particularly, in older adults, there is a strong consensus that other simple anthropometric measures should
be considered for assessment of adiposity, over and above
BMI. While the R2 in our modeling did not differ greatly
(Table 7), using WC may still be an important anthropometric variable to measure. Not considering WC as an
alternative measure may ignore a considerable sample of
subjects at otherwise risk of adverse outcomes as we previously have demonstrated [32] suggesting the need for future analyses to determine the impact of these combined
metrics on outcomes.
Lastly, sarcopenia, the loss of muscle mass and quality
with aging [33,34], impacts function and quality of life,
and may be particularly present in subjects with OA
[35]. WC is strongly associated with sarcopenic obesity
and insulin resistance [36], both of which are related to
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functional decline, frailty and disability, and thought to
be partially mediated by an increase in pro-inflammatory
markers, including IL-1, IL-6, and TNF-a. Additionally,
leptin levels are also associated both prevalent and incident central obesity and OA [37]. We suspect that there
may be a link between the functional decline observed
in the highest WC group in those with OA that may potentially be leptin-mediated. We also suspect that higher
degrees of pro-inflammatory cytokines viscerally may be
implicated in this phenomenon. Whether the alterations
in body composition due to progressive replacement of
muscle mass by fat mass, in addition to loss of skeletal
muscle mass and function in the aging process may be
implicated in this functional decline needs further evaluation. Future study should further examine whether leptin and changes in pro-inflammatory cytokine levels
predict functional impairment longitudinally.

Conclusion
In older adults, high waist circumference is associated
with worsening self-reported quality of life and physical
activity scores. Clinicians should consider not only targeting this subgroup for aggressive weight management
to prevent such functional decline, but also encourage
strengthening exercises and increases in physical activity levels which both can improve joint pain and may
improve overall walking performance.
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